2011
DOI: 10.1128/aac.01764-10
|View full text |Cite
|
Sign up to set email alerts
|

Symmetry Requirements for Effective Blocking of Pore-Forming Toxins: Comparative Study with α-, β-, and γ-Cyclodextrin Derivatives

Abstract: We compared the abilities of structurally related cationic cyclodextrins to inhibit Bacillus anthracis lethal toxin and Staphylococcus aureus ␣-hemolysin. We found that both ␤-and ␥-cyclodextrin derivatives effectively inhibited anthrax toxin action by blocking the transmembrane oligomeric pores formed by the protective antigen (PA) subunit of the toxin, whereas ␣-cyclodextrins were ineffective. In contrast, ␣-hemolysin was selectively blocked only by ␤-cyclodextrin derivatives, demonstrating that both symmetr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
44
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
7
2

Relationship

3
6

Authors

Journals

citations
Cited by 29 publications
(44 citation statements)
references
References 12 publications
0
44
0
Order By: Relevance
“…Inhibiting the effects of PFTs on host epithelia also increases survival of the host during S. pneumoniae infection (436). Further examples are cyclodextrin derivatives, which can disable B. anthracis PA pores and S. aureus alpha-toxin pores in vitro and protect mice from killing by anthrax in vivo (477,478), and pore-dead PFTs or other compounds used as competitive inhibitors of live PFTs (479,480). Other, hypothetical mechanisms include the administration of decoy membranes (330) and methods to inhibit expression or release of PFTs.…”
Section: Pfts As Targets For Antimicrobial Prophylactics and Therapeumentioning
confidence: 99%
“…Inhibiting the effects of PFTs on host epithelia also increases survival of the host during S. pneumoniae infection (436). Further examples are cyclodextrin derivatives, which can disable B. anthracis PA pores and S. aureus alpha-toxin pores in vitro and protect mice from killing by anthrax in vivo (477,478), and pore-dead PFTs or other compounds used as competitive inhibitors of live PFTs (479,480). Other, hypothetical mechanisms include the administration of decoy membranes (330) and methods to inhibit expression or release of PFTs.…”
Section: Pfts As Targets For Antimicrobial Prophylactics and Therapeumentioning
confidence: 99%
“…This led researchers to a design of synthetic tailor-made cationic 7-positively charged blockers based on a sevenfold symmetrical β-cyclodextrin (7+βCD) core (reviewed in [103]) (Table 38.2). The designed compounds have shown in vitro, in cell cultures, and in vivo (in the case of anthrax toxin) activity against four different binary bacterial toxins (i.e., anthrax, C2, iota, and CDT), thus representing the potential for the development of universal blockers against these toxins [77,84,89,[104][105][106][107]. The cyclodextrins, which are cyclic oligomers of glucose, have a long and successful history of being employed in the pharmaceutical, agrochemical, environmental, cosmetic, and food industries [108] because of their ability to form water-soluble inclusion complexes with different small molecules and portions of large molecules.…”
Section: Polyvalent Cationic Pore Blockersmentioning
confidence: 99%
“…Activity of the guanidine-substituted cyclodextrin compounds was decreased only slightly compared to the aminoalkyl analogs. To identify an optimum length of the linkers [104,105,107] which connect the positively charged ligands with the 7+β-CD scaffold, the blocker effect was examined using a group of hepta-6-thioaminoalkyl derivatives with alkyl spacers of various lengths both against PA 63 channels in planar lipid bilayer membranes and in cell models.…”
Section: Polyvalent Cationic Pore Blockersmentioning
confidence: 99%
“…69 However, they also showed -hemolysin produced from S. aureus which was selectively blocked only by -CD derivatives, suggesting the pore inhibition mode depends on both symmetry and size of the CD inhibitor.…”
Section: Mechanism Of Antimicrobial Actionmentioning
confidence: 99%